• A Case of Pernicious Anemia with Concurrent Beta-Thalassemia Minor
• A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-beta-Thalassemia Patients
• A comprehensive review on the current status of CRISPR based clinical trials for rare diseases
• A high stable sample loading for analysis of adult alpha-thalassemia via the improved microarray isoelectric focusing of Hb species
• A large cohort of Hb H disease in northeast Thailand: A molecular revisited, diverse genetic interactions and identification of a novel mutation
• A New Formula Based on Simple Blood Indices to Differentiate Beta Thalassemia Trait from Iron Deficiency Anemia
• A Novel beta-Globin Variant, Hb Odder [HBB: C.316C > G; CD105 (Leu > Val)]
• A Novel Frameshift Mutation of HBB Causing Dominant beta-Thalassemia in a Chinese Individual
• A Rare Case of De Novo Beta-Thalassemia Diagnosed by Whole-Genome Sequencing in an Ethnically Danish Newborn
• A Review of Gene Therapies for Hemoglobinopathies
• Active spread of beta-thalassemia beyond the thalassemia belt: A study on a Russian population
• Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes
• Allogeneic Hematopoietic Stem Cell Transplantation-Induced Anaphylaxis in 2 Pediatric Cases
• alpha-Globin mutations and Genetic Variants in gamma-globin Promoters are Associated with Unelevated Hemoglobin F Expression of Atypical beta(0)-thalassemia/HbE
• An Investigation of Group-Based Mobile Learning on Stress, Anxiety, Depression, and Pain Among Beta-Thalassemia Major Patients: A Randomized Control Trial
• Analysis of the Gene Mutation Type and Frequency of Thalassemia Patients in Jingzhou Area
• Anemia and iron overload as prognostic markers of outcomes in beta-thalassemia
• Appropriateness of the EQ-5D-5L in capturing health-related quality of life in individuals with transfusion-dependent beta-thalassemia: a mixed methods study
• Arrhythmias During Pregnancy: Ventricular Tachycardia in the Setting of Maternal Beta Thalassemia Minor
• Assessing NESTROFT as a preliminary screening tool for thalassemia in the Malayali tribes of Dharmapuri district, Tamil Nadu, India
• Assessing Psychological Disorders in Turkish Adolescents with Transfusion-Dependent Thalassemia
• Association between Epicardial Adipose Tissue and Atrial Fibrillation in Patients with Transfusion-Dependent beta-Thalassemia
• Association of serum ferritin trends with liver enzyme patterns in beta-thalassemia major: A longitudinal correlational study
• Autosomal Recessive Hyper-IgE Syndrome in a Child With Beta Thalassemia Trait: A Case Report
• Beta-thalassemia intermedia due to a complex alpha-globin rearrangement and a heterozygous beta thalassemia mutation
• Beta-Thalassemia Major and Myocardial Iron Overload: A Longitudinal Study with Magnetic Resonance Imaging
• Burden of rare genetic disorders in India: twenty-two years' experience of a tertiary centre
• Casgevy: Innovative Medicinal Products Require Innovative Approaches to Regulatory Assessment
• Catalase, Glutathione Peroxidase, and Peroxiredoxin 2 in Erythrocyte Cytosol and Membrane in Hereditary Spherocytosis, Sickle Cell Disease, and beta-Thalassemia
• Causes of Death and Mortality Trends in Individuals with Thalassemia in the United States, 1999-2020
• Characterization and Clinical Assessment of a Peculiar Case of Hemolytic Anemia
• Clinical characteristics, laboratory features and genetic profile of hemoglobin E (HBB:c.79 G > A)/beta (nucleotide -28 A > G) (HBB:c.-78 A > G) -thalassemia subjects identified from community- and hospital-recruited cohorts
• Clinical efficacy of thalidomide for various genotypes of beta thalassemia
• Comment on: Severe beta-thalassemia (Hb Zunyi) mimicking congenital dyserythropoietic anemia-The deceivingly normal mean corpuscular volume and hemoglobin electrophoresis in dominantly inherited beta-thalassemia: Hb Little Venice
• Correlation between plasma biochemical parameters and cardio-hepatic iron deposition in thalassemia major patients
• Correlation of Electrocardiographic and Echocardiographic Changes with Serum Ferritin Level in Multi-Transfused beta-Thalassemia Major Patients
• Cross-sectional study on the impact of cardiac and hepatic iron overload, as measured by MRI T2*, on the quality of life in children with severe beta-thalassemia major
• Diagnostic test performance of the Mentzer index in evaluating Saudi children with microcytosis
• Differential detection of megakaryocytic and erythroid DNA in plasma in hematological disorders
• Distinguishing Iron Deficiency Anemia From Beta-Thalassemia Trait: Comparative Analysis of CRUISE Index and Other Traditional Diagnostic Indices
• Dominant Beta Thalassemia: A Very Rare Cause of Thalassemia in a Mediterranean Country
• Early Detection of Renal Complication in Children With Sickle Cell Disease: A Single Center Prospective Study
• Erythroferrone in focus: emerging perspectives in iron metabolism and hematopathologies
• Evaluation of a point-of-care rapid diagnostic test kit (SICKLECHECK) for screening of sickle cell diseases
• Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives
• Exploring the Clinical and Hematological Characteristics of Beta-Thalassemia Trait: A Comprehensive Analysis in a Tertiary Care Hospital Setting
• Exploring the Perceptions and Experiences of female's with ss-Thalassemia Major in a Tertiary Care Private Hospital in Pakistan
• EXPRESS: Soluble Fms-Like Tyrosine Kinase-1 as an Endothelial Dysfunction Biomarker Associated with Pulmonary Hypertension in Adult Patients with Beta-Thalassemia Major
• Extramedullary Hematopoiesis Spinal Cord Compression in Beta-thalassemia: Role of Reirradiation as a Challenging Therapeutic Approach in Recurrent Disease
• Factors Associated With Quality of Life Among Adolescent With Beta Thalassemia in Indonesia: A Cross-Sectional Study
• Fat Embolism Syndrome Mimicking Thrombotic Thrombocytopenic Purpura in a Patient With Hemoglobin S/Beta-Thalassemia
• Gene editing of the endogenous cryptic 3' splice site corrects the RNA splicing defect in the beta654-thalassemia mouse model
• Gene therapy and gene editing strategies in inherited blood disorders
• Genetic Correlation of HBB, HFE and HAMP Genes to Endocrinal Complications in Egyptian Beta Thalassemia Major Patients
• Genome editing in K562 cells suggests a functional role for the XmnI Gg polymorphism: a widely used genetic marker in beta-thalassemia and sickle cell disease patients
• Global and regional cardiac magnetic resonance feature tracking left ventricular strain analysis in assessing early myocardial disease in beta thalassemia major patients
• Global longitudinal strain by cardiac magnetic resonance is associated with cardiac iron and complications in beta-thalassemia major patients
• HbA2 levels in children with beta-thalassemia trait associated with iron deficiency: A perspective for pediatricians
• Health-related Quality of Life of Omani Adult Patients with beta-Thalassemia Major at Sultan Qaboos University Hospital
• Hematopoietic Stem Cell Transplantation in Children with Sickle Cell Disease and Thalassemia Major: A National Database Study
• Hospitalization Events Among Adolescents and Adults With Sickle Cell Disease in a Tertiary Care Center in Central India
• How I treat iron overload in adult myelodysplastic syndrome
• Hydroxyurea achieved a hematologic response in a patient with beta-thalassemia and secondary severe thrombocytosis post splenectomy
• Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study
• Importance of CD71(+) Erythrocyte Cell Levels in Prognosis in Patients With beta-Thalassemia
• International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced
• Machine Learning-Based Prediction of Hemoglobinopathies Using Complete Blood Count Data
• Manuka combinations with nigella sativa and hydroxyurea in treating iron overload of pediatric beta-thalassemia major, randomized clinical trial
• Molecular Diagnosis and Pedigree Analysis of Rare Mutations in Non-coding Region of <em>HBA2</em> Gene
• Multidisciplinary Management of Oral Manifestations in Pregnant Women with Beta-Thalassemia Major: A Case Report
• Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
• Mutation Analysis of Exon 1 in the Hemoglobin Subunit Beta (HBB) Gene in Beta-Thalassemia
• Neuroimaging in the diagnosis and treatment of cerebral toxoplasmosis in children with severe beta-thalassemia after allo-HSCT
• Noninvasive Prenatal Genetic Screening of Cell-Free Fetal DNA for Early Prediction of beta-Thalassemia Using Fiber Optic Nanogold-Linked Sorbent Assay
• Optimizing the management of inherited blood disorders in a changing market: Findings from the AMCP Market Insights Program
• Outcome of Cyclophosphamide Treatment Following Hematopoietic Stem Cell Transplantation in a Thalassemia Patient: A Case Study
• Ovarian Tissue Cryopreservation for Fertility Preservation in Patients with Hemoglobin Disorders: A Comprehensive Review
• Overview of new approaches to beta-thalassemia treatment
• Post-GWAS Validation of Target Genes Associated with HbF and HbA₂ Levels
• Prenatal Diagnosis of Cystic Fibrosis by Celocentesis
• Prevalence and Regional Distribution of Beta-Hemoglobin Variants in Saudi Arabia: Insights from the National Premarital Screening Program"
• Prevalence and risk factors predisposing low bone mineral density in patients with thalassemia
• Prevalence of HIV, hepatitis B and hepatitis C infections among patients with thalassemia attending a tertiary care (rural) hospital
• Radiological Features of Extramedullary Hematopoiesis in a Young Male With Beta-Thalassemia: A Case Report
• Serum Iron and Ferritin Levels in Beta Thalassemia Carriers in Duhok Governorate, Iraq
• Serum visfatin level in beta-thalassemia and its correlation with disease severity
• Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach
• Splenectomy in Thalassemia: The Role of Surgery as an Adjunct to Medical Management
• Studies of Exagamglogene Autotemcel - Age and Place
• Studies of Exagamglogene Autotemcel - Age and Place. Reply
• Support Vector Machine-Based Formula for Detecting Suspected alpha Thalassemia Carriers: A Path toward Universal Screening
• Thalassemia Genotypes and HbA2 levels of Children in Wuzhou, Guangxi
• The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies
• The effect of blood transfusion on serum hepcidin levels in chronically transfused patients of beta-thalassemia major: An observational study in a tertiary care centre in Western Maharashtra
• The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/beta-thalassaemia and no or low HbA expression
• The relationship between liver stiffness by two-dimensional shear wave elastography and iron overload status in transfusion-dependent patients
• The Relevance of beta-Thalassemia Heterozygosity in Pediatric Clinical Practice: Croatian Experience
• The search for pyruvate kinase-R activators; from a HTS screening hit via an impurity to the discovery of a lead series
• Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches
• Transcriptional Repressor BCL11A in Erythroid Cells